Herbert I. Jacobson

2.2k total citations
55 papers, 1.6k citations indexed

About

Herbert I. Jacobson is a scholar working on Genetics, Molecular Biology and Oncology. According to data from OpenAlex, Herbert I. Jacobson has authored 55 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Genetics, 18 papers in Molecular Biology and 10 papers in Oncology. Recurrent topics in Herbert I. Jacobson's work include Estrogen and related hormone effects (21 papers), Cancer Risks and Factors (9 papers) and Chemical Synthesis and Analysis (5 papers). Herbert I. Jacobson is often cited by papers focused on Estrogen and related hormone effects (21 papers), Cancer Risks and Factors (9 papers) and Chemical Synthesis and Analysis (5 papers). Herbert I. Jacobson collaborates with scholars based in United States, Germany and Chile. Herbert I. Jacobson's co-authors include James A. Bennett, Elwood V. Jensen, Gerald J. Mizejewski, Thomas T. Andersen, Dwight T. Janerich, Chung Lee, W. Douglas Thompson, Fassil B. Mesfin, Ronald G. Harvey and James A. Bennett and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

Herbert I. Jacobson

55 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Herbert I. Jacobson United States 27 566 504 409 175 166 55 1.6k
Thomas J. Brown United States 24 651 1.2× 536 1.1× 242 0.6× 305 1.7× 77 0.5× 66 2.6k
Rocio Garcı́a-Becerra Mexico 25 744 1.3× 323 0.6× 425 1.0× 177 1.0× 95 0.6× 74 1.8k
Susan Friedman United States 16 397 0.7× 246 0.5× 182 0.4× 103 0.6× 103 0.6× 49 946
Henry Simpkins United States 25 1.1k 2.0× 127 0.3× 424 1.0× 63 0.4× 80 0.5× 79 1.8k
John C.M. Tsibris United States 29 782 1.4× 196 0.4× 111 0.3× 140 0.8× 203 1.2× 71 2.2k
Lars H. Breimer United Kingdom 19 1.3k 2.3× 175 0.3× 267 0.7× 200 1.1× 78 0.5× 68 2.1k
François Hyafil France 14 1.2k 2.2× 170 0.3× 491 1.2× 181 1.0× 180 1.1× 17 2.0k
Donald C. Smith United States 17 205 0.4× 498 1.0× 160 0.4× 58 0.3× 154 0.9× 74 1.6k
W J Nooijen Netherlands 19 528 0.9× 129 0.3× 1.3k 3.2× 314 1.8× 154 0.9× 29 1.9k
Masataka Harada Japan 16 822 1.5× 130 0.3× 842 2.1× 106 0.6× 77 0.5× 45 2.2k

Countries citing papers authored by Herbert I. Jacobson

Since Specialization
Citations

This map shows the geographic impact of Herbert I. Jacobson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Herbert I. Jacobson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Herbert I. Jacobson more than expected).

Fields of papers citing papers by Herbert I. Jacobson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Herbert I. Jacobson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Herbert I. Jacobson. The network helps show where Herbert I. Jacobson may publish in the future.

Co-authorship network of co-authors of Herbert I. Jacobson

This figure shows the co-authorship network connecting the top 25 collaborators of Herbert I. Jacobson. A scholar is included among the top collaborators of Herbert I. Jacobson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Herbert I. Jacobson. Herbert I. Jacobson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Jacobson, Herbert I., et al.. (2009). A Proposed Unified Mechanism for the Reduction of Human Breast Cancer Risk by the Hormones of Pregnancy. Cancer Prevention Research. 3(2). 212–220. 9 indexed citations
3.
Joseph, Leroy C., James A. Bennett, Karl N. Kirschner, et al.. (2009). Antiestrogenic and anticancer activities of peptides derived from the active site of alpha‐fetoprotein. Journal of Peptide Science. 15(4). 319–325. 11 indexed citations
4.
Jensen, Elwood V., Herbert I. Jacobson, Alicia A. Walf, & Cheryl A. Frye. (2009). Estrogen action: A historic perspective on the implications of considering alternative approaches. Physiology & Behavior. 99(2). 151–162. 91 indexed citations
5.
Jacobson, Herbert I., et al.. (2008). Hormones of Pregnancy, α-Feto Protein, and Reduction of Breast Cancer Risk. Advances in experimental medicine and biology. 617. 477–484. 11 indexed citations
6.
Andersen, Thomas T., et al.. (2007). An α-fetoprotein-derived peptide reduces the uterine hyperplasia and increases the antitumour effect of tamoxifen. British Journal of Cancer. 97(3). 327–333. 12 indexed citations
7.
Bennett, James A., et al.. (2006). AFPep: an anti-breast cancer peptide that is orally active. Breast Cancer Research and Treatment. 98(2). 133–141. 29 indexed citations
8.
Mesfin, Fassil B., Leroy C. Joseph, D. McLeod, et al.. (2004). Synthetic peptide derived from α‐fetoprotein inhibits growth of human breast cancer: investigation of the pharmacophore and synthesis optimization. Journal of Peptide Research. 63(5). 409–419. 26 indexed citations
9.
Eisele, Leslie E., Robert MacColl, Gerald J. Mizejewski, et al.. (2001). Studies on a growth‐inhibitory peptide derived from alpha‐fetoprotein and some analogs. Journal of Peptide Research. 57(1). 29–38. 29 indexed citations
10.
Mesfin, Fassil B., et al.. (2001). Development of a synthetic cyclized peptide derived from α‐fetoprotein that prevents the growth of human breast cancer. Journal of Peptide Research. 58(3). 246–256. 34 indexed citations
11.
Mesfin, Fassil B., et al.. (2000). Alpha-fetoprotein-derived antiestrotrophic octapeptide. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1501(1). 33–43. 40 indexed citations
12.
Bennett, James A., et al.. (1997). Similarity between natural and recombinant human alpha-fetoprotein as inhibitors of estrogen-dependent breast cancer growth. Breast Cancer Research and Treatment. 45(2). 169–179. 36 indexed citations
13.
Nasca, Philip C., Simin Liu, Mark S. Baptiste, et al.. (1994). Alcohol Consumption and Breast Cancer: Estrogen Receptor Status and Histology. American Journal of Epidemiology. 140(11). 980–988. 48 indexed citations
14.
Allen, S.H.G., et al.. (1993). Purification of alpha-fetoprotein from human cord serum with demonstration of its antiestrogenic activity. Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology. 1202(1). 135–142. 27 indexed citations
15.
Nasca, Philip C., Mark S. Baptiste, Barbara Metzger, et al.. (1990). An Epidemiological Case-Control Study of Breast Cancer and Alcohol Consumption. International Journal of Epidemiology. 19(3). 532–538. 47 indexed citations
16.
Janerich, Dwight T., Susan T. Mayne, W. Douglas Thompson, et al.. (1990). Familial Clustering of Neural Tube Defects and Gastric Cancer. International Journal of Epidemiology. 19(3). 516–521. 8 indexed citations
17.
Thompson, W. Douglas, et al.. (1989). Hypertension, Pregnancy, and Risk of Breast Cancer. JNCI Journal of the National Cancer Institute. 81(20). 1571–1574. 57 indexed citations
18.
Jacobson, Herbert I., W. Douglas Thompson, & Dwight T. Janerich. (1989). MULTIPLE BIRTHS AND MATERNAL RISK OF BREAST CANCER. American Journal of Epidemiology. 129(5). 865–873. 56 indexed citations
19.
Mizejewski, Gerald J. & Herbert I. Jacobson. (1987). Biological activities of alpha 1-fetoprotein. CRC Press eBooks. 8 indexed citations
20.
Holt, John A., G. Schumacher, Herbert I. Jacobson, & Donald Swartz. (1979). Estrogen and Progestin Binding and Changes in Secretions by Human Cervical Tissue During the Ovarian Cycle. Fertility and Sterility. 32(2). 170–176. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026